Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury

Author： Paola Rosanna   Cuzzocrea Salvatore  

Publisher： Springer Publishing Company

ISSN： 0028-1298

Source： Naunyn-Schmiedeberg's Archives of Pharmacology, Vol.375, Iss.3, 2007-05, pp. : 157-175

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Targeting the peroxisome proliferator-activated receptors (PPARs) in spinal cord injury

By Esposito Emanuela   Cuzzocrea Salvatore  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 8, 2011-08 ,pp. : 943-959

Informa Healthcare

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor ligands in atherosclerosis

By Viles-Gonzalez Juan F   Choi Brian G   Fuster Valentin   Badimon Juan J  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1393-1403

Informa Healthcare

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptors and the Control of Inflammation Update

By  

Medicinal Chemistry Reviews - Online, Vol. 1, Iss. 3, 2004-07 ,pp. : 297-298

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptors and their Ligands: Entry Into the Post-Glucocorticoid Era of Skin Treatment?

By Weindl Günther  

Drugs, Vol. 65, Iss. 14, 2005-01 ,pp. : 1919-1934

Adis International

Access to resources Recommend Favorite

Peroxisome proliferator activated receptors and obesity

By Kersten S.  

European Journal of Pharmacology, Vol. 440, Iss. 2, 2002-04 ,pp. : 223-234

Elsevier

Access to resources Recommend Favorite